Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Seattle Genetics
Biotech
Seattle Genetics' ADC curbs hard-to-treat cervical cancer
Seattle Genetics and Genmab’s antibody-drug conjugate shrank tumors in 24% of patients with cervical cancer, stopping tumor growth in half of them.
Amirah Al Idrus
Sep 21, 2020 10:20am
Seattle gets second prize in a mini ADC weekend frenzy
Sep 14, 2020 6:45am
Genmab, Seattle Genetics eye FDA filing after seeing cancer data
Jun 30, 2020 7:20am
How a Seattle Genetics cancer drug could help lupus patients
Apr 9, 2020 8:35am
Silverback Therapeutics bags $79M for antibody-drug conjugates
Mar 11, 2020 7:30am
Five Prime grabs $5M lifeline in Seattle Genetics ADC deal
Feb 19, 2020 4:08pm
